Investor profile
EMV Capital plc
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
EMV Capital plc is a deep tech and life sciences venture capital investment group with a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future. The firm invests in, manages, and strengthens early stage IP-rich companies. EMV Capital's approach is characterised by its proactive management style, aiming to advance companies to critical value inflection points. The firm's investment thesis is realised through three capital sources: capital-efficient investments through PLC balance sheet; fund management of the Evergreen EIS and Martlet Capital Funds; and syndicated investments leveraging its extensive network of third-party investors. EMV Capital holds both direct equity stakes and carried interest in its portfolio companies, creating an evergreen structure that supports extensive growth and value creation. The firm concentrates on a select cohort of companies at a time, driving growth and investment realisations through fundraising support and value creation services.
Notable quotes
“EMV Capital has continued to make steady progress during 2025. We have maintained AUM above £100 million, completed the integration of Martlet Capital, advanced our Venture Building programme and supported a number of existing and new portfolio companies through important funding and commercial milestones.”
“Building on our work with Martlet Capital and our team's longstanding links to the cluster, EMV Capital PLC is continuing to deepen its presence within the Cambridge ecosystem. We have made further investments in Martlet portfolio companies such as Xampla, Qkine and OctaiPipe, and we plan to continue increasing our investment activity in the region.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Sofant Technologies | Series A | $11m | 2026-01-05 |
| Wanda Health | Series A | $7m | 2025-12-10 |
| Q-Bot | Series A | $5m | 2025-06-27 |
| SageTech Medical Equipment | Seed | $10m | 2024-11-20 |
| PDS Biotechnology | unknown | — | — |
| Cambridge GaN Devices | unknown | — | — |
| Paragraf | unknown | — | — |
| NU Quantum | unknown | — | — |
| Glycotest | unknown | — | — |
| EpiBone | unknown | — | — |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| Scottish Enterprise | 1 |
| Animal Health Angels | 1 |
Fit check
Is EMV Capital plc a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit